Brief: NeuroVive Announces Settlement In Dispute With CicloMulsion

Abliva AB

16/12/2019 10:03

Dec 16 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * NEUROVIVE ANNOUNCES SETTLEMENT IN DISPUTE WITH
CICLOMULSION AG
    * NEUROVIVE PHARMACEUTICAL AB - NEUROVIVE AND CICLOMULSION
AG HAVE
NOW FULLY AND FINALLY SETTLED DISPUTE
    * NEUROVIVE PHARMACEUTICAL AB - SETTLEMENT MEANS THAT
NEUROVIVE
SHALL NOT MAKE ANY PAYMENTS TO CICLOMULSION FOR CLAIMS MADE IN
ARBITRATION
    * NEUROVIVE PHARMACEUTICAL AB - ARBITRATION SHALL BE
TERMINATED,
AND EACH PARTY SHALL BEAR ITS OWN COSTS IN ARBITRATION
    * NEUROVIVE PHARMACEUTICAL AB - OWNERSHIP OF TECHNOLOGY
SHALL
REMAIN WITH NEUROVIVE, WHO SHALL THUS HAVE EXCLUSIVE RIGHTS
THERETO, AND NEUROVIVE SHALL NOT BE LIABLE FOR ANY FUTURE
ROYALTIES RELATING TO TECHNOLOGY

Source text for Eikon:  ID:nWkr1kRnzt 
Further company coverage:  NVP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))